Trials / Conditions / Glabellar Rhytides
Glabellar Rhytides
6 registered clinical trials studyying Glabellar Rhytides.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides NCT02261493 | Allergan | Phase 3 |
| Completed | A Safety and Efficacy Study of OnabotulinumtoxinA in Forehead and Glabellar Facial Rhytides NCT02261467 | Allergan | Phase 3 |
| Completed | Treatment With Botulinum Toxin Type A (BOTOX®) in Chinese Patients With Moderate to Severe Frown Lines NCT01814670 | Allergan | Phase 4 |
| Completed | A Long-Term Safety Study of Repeat Treatment With PurTox® for Frown Lines Between the Eyebrows NCT00752258 | Mentor Worldwide, LLC | Phase 3 |
| Completed | Safety and Efficacy Study of Repeat Treatment With PurTox® Botulinum Toxin Type A for Frown Lines Between the NCT00752050 | Mentor Worldwide, LLC | Phase 3 |
| Completed | Safety and Efficacy Study of PurTox® Botulinum Toxin Type A to Treat Frown Lines Between the Eyebrows NCT00752297 | Mentor Worldwide, LLC | Phase 3 |